153 related articles for article (PubMed ID: 31545413)
21. Selection of AECOPD-specific immunomodulatory biomarkers by integrating genomics and proteomics with clinical informatics.
Shi L; Zhu B; Xu M; Wang X
Cell Biol Toxicol; 2018 Apr; 34(2):109-123. PubMed ID: 28779230
[TBL] [Abstract][Full Text] [Related]
22. Serum exosomal microRNA-1258 may as a novel biomarker for the diagnosis of acute exacerbations of chronic obstructive pulmonary disease.
Wang F; Yang B; Qiao J; Bai L; Li Z; Sun W; Liu Q; Yang S; Cui L
Sci Rep; 2023 Oct; 13(1):18332. PubMed ID: 37884583
[TBL] [Abstract][Full Text] [Related]
23. Association between peripheral blood WBCs C3aR mRNA level and plasma C3a, C3aR, IL-1β concentrations and acute exacerbation of chronic obstructive pulmonary disease.
Li Z; He P; Ding H; Gong L; Wu J; Zhong C; Liu D
Immunobiology; 2022 Jan; 227(1):152164. PubMed ID: 34923262
[TBL] [Abstract][Full Text] [Related]
24. Identification of Macrophage Polarization-Related Genes as Biomarkers of Chronic Obstructive Pulmonary Disease Based on Bioinformatics Analyses.
Zhao Y; Li M; Yang Y; Wu T; Huang Q; Wu Q; Ren C
Biomed Res Int; 2021; 2021():9921012. PubMed ID: 34250093
[TBL] [Abstract][Full Text] [Related]
25. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease.
Ju CR; Liu W; Chen RC
Dis Markers; 2012; 32(5):281-7. PubMed ID: 22674408
[TBL] [Abstract][Full Text] [Related]
26. Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers.
Huebner ST; Henny S; Giezendanner S; Brack T; Brutsche M; Chhajed P; Clarenbach C; Dieterle T; Egli A; Frey M; Heijnen I; Irani S; Sievi NA; Thurnheer R; Trendelenburg M; Kohler M; Leuppi-Taegtmeyer AB; Leuppi JD
Respiration; 2022; 101(5):441-454. PubMed ID: 34942619
[TBL] [Abstract][Full Text] [Related]
27. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker.
Ruzsics I; Nagy L; Keki S; Sarosi V; Illes B; Illes Z; Horvath I; Bogar L; Molnar T
COPD; 2016; 13(2):139-45. PubMed ID: 26514682
[TBL] [Abstract][Full Text] [Related]
28. Possible mechanisms mediating apoptosis of bronchial epithelial cells in chronic obstructive pulmonary disease - A next-generation sequencing approach.
Tsai MJ; Chang WA; Jian SF; Chang KF; Sheu CC; Kuo PL
Pathol Res Pract; 2018 Sep; 214(9):1489-1496. PubMed ID: 30115538
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-218-5p inhibit the migration and proliferation of pterygium epithelial cells by targeting EGFR via PI3K/Akt/mTOR signaling pathway.
Han S; Chen Y; Gao Y; Sun B; Kong Y
Exp Eye Res; 2019 Jan; 178():37-45. PubMed ID: 30243568
[TBL] [Abstract][Full Text] [Related]
30. Expression and Clinical Significance of Serum Dipeptidyl Peptidase IV Chronic Obstructive Pulmonary Disease.
Chang XY; Yang Y; Jia XQ; Wang Y; Peng LN; Ai XH; Jiang CY; Guo JH; Wu TT
Am J Med Sci; 2016 Mar; 351(3):244-52. PubMed ID: 26992252
[TBL] [Abstract][Full Text] [Related]
31. Elevated levels of circulating exosome in COPD patients are associated with systemic inflammation.
Tan DBA; Armitage J; Teo TH; Ong NE; Shin H; Moodley YP
Respir Med; 2017 Nov; 132():261-264. PubMed ID: 28476471
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
[TBL] [Abstract][Full Text] [Related]
33. Protein Network Analysis Identifies Changes in the Level of Proteins Involved in Platelet Degranulation, Proteolysis and Cholesterol Metabolism Pathways in AECOPD Patients.
Tan DBA; Ito J; Peters K; Livk A; Lipscombe RJ; Casey TM; Moodley YP
COPD; 2020 Feb; 17(1):29-33. PubMed ID: 31920121
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of IGFBP7 are elevated during acute exacerbation in COPD patients.
Ruan W; Wu M; Shi L; Li F; Dong L; Qiu Y; Wu X; Ying K
Int J Chron Obstruct Pulmon Dis; 2017; 12():1775-1780. PubMed ID: 28684903
[TBL] [Abstract][Full Text] [Related]
35. [The role of 4-hydroxynonenal in assessment of chronic obstructive pulmonary disease severity].
Liu H; Xu JY
Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):758-61. PubMed ID: 23289993
[TBL] [Abstract][Full Text] [Related]
36. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.
Polatli M; Cakir A; Cildag O; Bolaman AZ; Yenisey C; Yenicerioglu Y
J Thromb Thrombolysis; 2008 Oct; 26(2):97-102. PubMed ID: 17622488
[TBL] [Abstract][Full Text] [Related]
37. MiR-543 Regulates the Development of Chronic Obstructive Pulmonary Disease by Targeting Interleukin-33.
He H; Wang H; Pei F; Jiang M
Clin Lab; 2018 Jul; 64(7):1199-1205. PubMed ID: 30146845
[TBL] [Abstract][Full Text] [Related]
38. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
Li Y; Ma X; Wang Y; Li G
Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
[TBL] [Abstract][Full Text] [Related]
39. Sputum Cytokine Profiling in COPD: Comparison Between Stable Disease and Exacerbation.
Barta I; Paska C; Antus B
Int J Chron Obstruct Pulmon Dis; 2022; 17():1897-1908. PubMed ID: 36017119
[TBL] [Abstract][Full Text] [Related]
40. A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype.
Hirai K; Shirai T; Suzuki M; Akamatsu T; Suzuki T; Hayashi I; Yamamoto A; Akita T; Morita S; Asada K; Tsuji D; Inoue K; Itoh K
Clin Exp Allergy; 2017 Nov; 47(11):1374-1382. PubMed ID: 28658564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
